Investors

Investing in a next-generation biotech platform

Aramis is a Canadian biotechnology company that operates a proven plant-based platform for the development and production of recombinant proteins and high-value molecules for the health, agriculture and biosolutions markets.

With intellectual property developed over more than 20 years, a highly specialized team and manufacturing infrastructure unique in Canada, Aramis has a solid foundation to support its growth and innovation.

The company stands out for its Canadian roots, its commitment to ESG principles and its ability to transform cutting-edge technology into high value-added solutions. For investors, Aramis represents an opportunity to participate in the development of a differentiated technology platform, supported by recognized expertise and significant commercialization potential.